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Short interfering RNA (siRNA) attracts much attention for the treatment of various diseases. However, its delivery, especially via systemic routes,
remains a challenge. Indeed, naked siRNAs are rapidly degraded, while complexed siRNAs massively aggregate in the blood or are captured by
macrophages. Although this can be circumvented by PEGylation, we found that PEGylation had a strong negative effect on the gene silencing
efficiency of siRNA–liposome complexes (siPlexes). Recently, ultrasound combined with microbubbles has been used to deliver naked siRNA but
the gene silencing efficiency is rather low and very high amounts of siRNA are required. To overcome the negative effects of PEGylation and to
enhance the efficiency of ultrasound assisted siRNA delivery, we coupled PEGylated siPlexes (PEG-siPlexes) to microbubbles. Ultrasound radiation
of these microbubbles resulted in massive release of unaltered PEG-siPlexes. Interestingly, PEG-siPlexes loaded on microbubbles were able to enter
cells after exposure to ultrasound, in contrast to free PEG-siPlexes, which were not able to enter cells rapidly. Furthermore, these PEG-siPlex loaded
microbubbles induced, in the presence of ultrasound, much higher gene silencing than free PEG-siPlexes. Additionally, the PEG-siPlex loaded
microbubbles only silenced the expression of genes in the presence of ultrasound, which allows space and time controlled gene silencing.
© 2007 Elsevier B.V. All rights reserved.Keywords: siRNA delivery; Delivery vehicle; PEGylation; Ultrasound; Targeting; Microbubbles1. Introduction
RNA interference (RNAi), a naturally occurring process of
sequence-specific post-transcriptional gene silencing, is an
important biological process for modulating gene expression.
The silencing effect of RNAi is highly potent and requires only
that the sequence of the target RNA is known. One approach to
evoke RNAi in target cells is by the delivery of chemically
synthesized siRNAs, which results in a sequence-specific,
robust silencing of the targeted gene [1]. The potential of
siRNA molecules as therapeutic agent in the treatment of e.g.
cancer, viral infections, arthritis, Huntington's disease and⁎ Corresponding authors. Ghent University, Laboratory of General Biochem-
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doi:10.1016/j.jconrel.2007.12.001hypercholesterolemia has been widely studied [2]. However,
cells do not readily take up siRNAs. Therefore, clinical
applications of siRNA largely depend on the development of
delivery systems that can bring intact siRNA into the cytoplasm
of the target cells of a patient.
Strategies that have been considered for in vivo delivery of
synthetic siRNA in laboratory animals are hydrodynamic in-
jection of naked siRNA [3] or siRNA conjugates [4], electro-
poration [5–8] and the use of cationic carriers [9–14]. However,
several aspects limit the applicability of thesemethods in humans.
Indeed, hydrodynamic injection, which involves the intravascular
injection of large volumes, generates high pressure in the vascular
system and therefore often results in heart failure. Additionally,
undesirable gene suppression may be induced in non-target
organs. Electroporation allows targeting, but requires the insertion
of electrodes into the target area, and hence invasive procedures
that limit its range of application. Cationic siRNA delivery
carriers, such as cationic lipids and polymers, are often cytotoxicdelivery using PEG-siPlex loaded microbubbles, J. Control. Release (2008),
G
E
N
E
D
E
L
IV
E
R
Y
2 R.E. Vandenbroucke et al. / Journal of Controlled Release xx (2008) xxx–xxx
ARTICLE IN PRESSand/or not very efficient. Furthermore, they are often not suited
for systemic application since their positively charged surface
makes them vulnerable to non-specific interactions with blood
compounds, leading to life-threatening aggregates and a rapid
clearance by the mononuclear phagocyte system [15,16]. A
common approach for reducing these undesired interactions is by
masking the cationic surface of the nanoparticles with hydrophilic
polymers, such as polyethylene glycol (PEG). This prevents the
aggregation of these nucleic acid containing nanoparticles in
blood and prolongs their circulation time [17–20]. However, it
has been observed by many groups that shielding the surface of
non-viral gene delivery systemswith polymers like PEG leads to a
drastic reduction in gene transfer, due to a reduced cellular uptake
or limited endosomal release [21,22].
The use of ultrasound energy has intensively been studied for
pDNA delivery [23–30]. Recently, ultrasound in combination
with microbubbles has also been used in two reports to deliver
naked siRNA [31,32]. However, the gene silencing efficiency in
these studies was rather low and very high amounts of siRNA
were required. Nevertheless, ultrasound assisted drug delivery
is considered as rather safe as ultrasound, in combination with
microbubbles, is routinely used in the clinic for diagnostic
purposes. It is believed that ultrasound, especially when com-
bined with microbubbles, causes small (100 to a few 100 nm
large) transient pores in the cell membrane which allows large
molecules to enter the cell cytoplasm [33]. These perforations
are caused by microjets that are generated by the ultrasound
induced cavitation, i.e. alternate growing and shrinking of
microbubbles, and implosion of microbubbles. The lifetime of
these pores in the cell membranes is very short, i.e. milliseconds
to seconds [34], making high concentrations of nucleic acids in
the surrounding of the cells beneficial to ensure that a signi-
ficant amount of nucleic acids can enter the cells through these
short-living pores. Consequently, as recently shown by our
group for pDNA, microbubbles that at the same time perforate
cells and release massive amounts of nucleic acids containing
nanoparticles near these perforations may drastically enhance
the cellular uptake and hence the biological activity of nucleic
acids [35].
Therefore, the aim of this study was to evaluate (a) the
loading and release of PEGylated siRNA–liposome complexes
(PEG-siPlexes) on/off ultrasound responsive microbubble, and
(b) the cellular distribution and gene silencing efficiency of the
PEG-siPlex loaded microbubbles after ultrasound radiation.
2. Materials and methods
2.1. Cell culture
HUH7 and HUH7eGFPLuc cells were cultured in Dulbec-
co's modified Eagle's medium supplemented with F12 (DMEM:
F12) containing 2mMglutamine, 10% heat-inactivated FBS and
100 U/ml penicilline/streptomycine at 37 °C in a humidified
atmosphere containing 5% CO2. All cell culture products were
purchased from Invitrogen (Merelbeke, Belgium).
HUH7eGFPLuc cells stably expressing eGFP-Luciferase
were generated by transfecting HUH7 cells with the vectorPlease cite this article as: R.E. Vandenbroucke, et al., Ultrasound assisted siRNA
doi:10.1016/j.jconrel.2007.12.001pEGFPLuc (Clontech, Palo Alto, USA). The vector was
linearized using the restriction enzyme DraIII and transfected
using linear polyethylenimine (PEI) 22 kDa. Transfected cells
were incubated in fresh medium for 72 h and then selected with
60 to 400 µg/ml G418. After several days, surviving cells were
seeded at low densities into 6-well plates in order to generate
separate colonies. Single cell clones were then isolated and
expanded. The generated clones were analyzed for the per-
centage of GFP-positive (eGFPLuc stably transfected) cells.
Clones with the highest number of GFP-positive cells were then
further selectively grown up under the above described selective
conditions and this procedure was repeated until all cells were
positive for GFP.
2.2. siRNA
Atto488-labelled and non-labelled siRNA duplexes against
firefly luciferase and control siRNA duplexes were purchased
from Eurogentec (Seraing, Belgium) and dissolved in RNase
free water at a final concentration of 20 µM.
2.3. Preparation and characterization of lipid microbubbles
1,2-Dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) and
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[biotinyl
(polyethylene glycol)2000] (ammonium salt) (DSPE-PEG2000-
biotin) were purchased from Avanti Polar Lipids (Alabaster, AL).
Lipid microbubbles were prepared from liposomes com-
posed of DPPC and DSPE-PEG2000-biotin with molar ratios of
95:5. Therefore, as described previously [36], appropriate
amounts of lipids were dissolved in chloroform and mixed.
The chloroform was subsequently removed by rotary evapora-
tion at 37 °C followed by flushing the obtained lipid film with
nitrogen during 30 min at room temperature. The dried lipids
were then hydrated by adding HEPES buffer (20 mM, pH 7.4)
till a final lipid concentration of 5 mg/ml. After mixing in the
presence of glass beads, liposome formation was allowed
overnight at 4 °C. Thereafter, the DPPC/DSPE-PEG2000-biotin
liposomes were extruded through two stacked 0.200 µm
polycarbonate membrane filters (Whatman; Brentfort, UK) at
55 °C using an Avanti Mini-Extruder (Avanti Polar Lipids).
Subsequently, the liposome suspension was sonicated with a
20 kHz probe (Branson 250 sonifier, Branson Ultrasonics
Corp.; Danbury, CT) in the presence of perfluorobutane gas
(MW 238 g/mol; F2 chemicals; Preston, Lancashire, UK). After
sonication, the lipid microbubbles were washed with 3 ml
HEPES buffer by 5 min centrifugation at 470 g. The amount of
microbubbles per ml was determined by light microscopy and
equalled 4×108 microbubbles/ml. The size distribution of the
microbubbles was determined by laser diffraction (Mastersizer
S, Malvern; Worcestershire, UK).
2.4. Preparation of avidin coated lipid microbubbles
Avidinylated microbubbles were prepared by incubating them
at room temperature with 500 µl avidin (10 mg/ml). After 10 min
of incubation, the microbubbbles were washed with 3 ml HEPESdelivery using PEG-siPlex loaded microbubbles, J. Control. Release (2008),
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10 ml. For the preparation of red labelled lipid microbubbles, the
microbubbles were incubated with the unlabelled avidin sup-
plemented with 50 µl Cy5-labelled streptavidin (1 mg/ml)
(Zymed Laboratories; San Francisco, CA).
2.5. Preparation and characterization of liposomes and
PEG-siPlexes
The cationic lipid 1,2-dioleoyl-3-trimethylammonium-pro-
pane (chloride salt) (DOTAP) and the helper lipid 1,2-dioleoyl-
sn-glycero-3-phosphoethanolamine (DOPE) were purchased
from Avanti Polar Lipids. Cationic liposomes containing
DOTAP and DOPE in a 1:1 molar ratio, supplemented with 0
to 15 mol% DSPE-PEG2000-biotin, were prepared at a final
DOTAP concentration of 5 mM. All liposomes were prepared as
described above for the DPPC/DSPE-PEG2000-biotin liposomes,
however extrusion occurred through two stacked 0.100 µm
polycarbonate membrane filters at room temperature. To obtain
(PEG-)siPlexes, equal volumes of siRNA solution and extruded
liposomes were mixed in a N:P ratio of 20:1. Subsequently, the
obtained mixture was vortexed for 5 s and incubated at room
temperature for 30 min.
The average particle size and the zeta potential (ζ) of the
(PEGylated) liposomes and siPlexes were measured by photon
correlation spectroscopy (PCS) (Malvern zetasizer nano ZS;
Malvern) and by particle electrophoresis (Malvern zetasizer
nano ZS; Malvern), respectively. Therefore, the liposome and
PEG-siPlex dispersions were diluted 40-fold in 20 mM HEPES
buffer. The size of the liposomes was independent of the degree
of PEGylation and averaged 120 nm. In contrast, the zeta
potential clearly dropped with increasing degree of PEGylation,
varying from ∼50 mV for the 0 mol% to ∼20 mV for the 5 mol
% DSPE-PEG2000-biotin containing DOTAP/DOPE liposomes
The size and zeta potential of the siPlexes are displayed in Fig. 5.
2.6. Preparation and characterization of siPlexes loaded
microbubbles
130 µl siPlex dispersion was mixed with 1 ml microbubbles,
vortexed shortly and incubated at room temperature for 5 min.
Subsequently, the size distribution of the siPlex loaded
microbubbles was determined as described for the non-loaded
microbubbles. The time-dependent stability of the (PEG-)
siPLex loaded microbubbles was followed for 36 h at room
temperature via light microscopy using a motorized Nikon
TE2000-E inverted microscope (Nikon Benelux, Brussels,
Belgium). The small microbubbles (b2 µm) were stable for at
least 24 h and the larger ones for at least 36 h.
2.7. Gel electrophoresis
(PEG-)siPlexes, before binding to the microbubbles and after
ultrasound induced release from the microbubbles, were loaded
on a native 20% polyacrylamide gel (PAGE). All samples were
supplemented with 10% glycerol and subjected to electrophor-
esis at 100 V for 2 h. Finally, the siRNA was stained withPlease cite this article as: R.E. Vandenbroucke, et al., Ultrasound assisted siRNA
doi:10.1016/j.jconrel.2007.12.0011:100,000 diluted SYBR-green II dye (Molecular Probes;
Merelbeke, Belgium) and visualized by UV transillumination.
2.8. Confocal laser scanning microscopy
The Cy5-streptavidin coated microbubbles and Atto488-
siRNA containing siPlexes were visualized using a Nikon C1si
confocal laser scanning module attached to a motorized Nikon
TE2000-E inverted microscope (Nikon Benelux; Brussels,
Belgium). Images were captured with a 60× objective lens
using the 488 nm line from an Ar-ion laser for the excitation of
Atto488-siRNA and the 639 nm laser line from a diode laser for
the excitation of Cy5-streptavidin.
2.9. Cellular distribution of PEG-siPlexes in HUH7 cells
Atto488-siRNA containing PEG-siPlexes (with 5 mol%
DSPE-PEG2000-biotin) were prepared as described above.
HUH7 cells were grown in OptiCells™ and incubated for
20 min with the free PEG-siPlexes or with the PEG-siPlexes
loaded microbubbles, immediately followed by ultrasound
treatment. The ultrasound settings were the same as in the
transfection experiments (see below). After one wash step with
phosphate buffered saline (PBS; Invitrogen), cells were treated
for 10 min with Draq5 (Biostatus Limited; Leicestershire, UK),
to stain the nucleus, and TRITC-concanavalin A (Molecular
Probes), to stain the cellular membrane. Subsequently, the
cellular distribution of the Atto488-siRNAwas visualized using
a Nikon EZC1-si confocal laser scanning microscope equipped
with a 60× objective. The 488 nm line of the Ar-ion laser was
used to excite the Atto488 label and the 639 nm line from a
diode laser to excite Draq5 and TRITC-concanavalin A.
2.10. Transfection experiments
HUH7eGFPLuc cells were seeded in OptiCell™ units
(Biocrystal; Westerville, OH) at 4×104 cells/cm2, and allowed
to attach overnight in a humidified incubator at 37 °C and 5%
CO2. The culture mediumwas removed from the cells and after a
washing step with PBS, the free siPlexes or siPlex loaded
microbubbles, both dissolved in OptiMEM (Invitrogen) and
containing 50 nM siRNA, were added to the OptiCell™ units.
Subsequently, the OptiCell™ units were placed in awater bath at
37 °Cwith an absorbing rubber at the bottom as shown in Fig. 1B
and immediately subjected to ultrasound radiation for 10 s with a
sonitron 2000 (RichMar; Inola, OK) equipped with a 22 mm
probe. It has been reported that standing waves can influence the
ultrasound assisted transfection efficiency dramatically [37]. In
our ultrasound set up (Fig. 1B) standing waves are eliminated as
much as possible by (1) using the ultrasound transparent
OptiCell™ units, (2) placing an absorbing rubber at the bottom
of the water bath and (3) degassing the water. In all experiments
the same ultrasound settings were applied: 1 MHz, 10% duty
cycle (DC) and an ultrasound intensity of 2 W/cm2 during 10 s.
After 2 h incubation of the cells (at 37 °C) with the free siPlexes
or siPlex loaded microbubbles, the transfection medium was
removed, cells were washed twice with PBS and culture mediumdelivery using PEG-siPlex loaded microbubbles, J. Control. Release (2008),
Fig. 2. Transmission image (A) and confocal laser scanning microscopy image
(B) of avidinylated microbubbles coated with Cy5-streptavidin (red). The inserts
display a close-up of three microbubbles.
Fig. 1. (A) Schematic overview of a PEG-siPlex loaded microbubble. The white
disk surrounded by lipids (95 mol% DPPC and 5 mol% DSPE-PEG-biotin)
represents an avidinylated lipid microbubble with its perfluorobutane (C4F10)
gas core. PEG-siPlexes with increasing amounts of DSPE-PEG-biotin were
attached to these avidinylated microbubbles via a biotin–avidin–biotin bridge.
(B) Experimental setup used in the transfection experiments. An OptiCell™ unit
containing a monolayer of HUH7 cells on one of their membranes was placed in
a water tank with a rubber plate, designed to minimize ultrasound reflection or
scattering, at the bottom. In all experiments the same ultrasound settings were
applied: 10 s, 1 MHz, 10% duty cycle and an ultrasound intensity of 2 W/cm2.
The ultrasound was delivered vertically to the cells which were present on the
upper membrane of the OptiCell™ unit, closest to the ultrasound probe.
Different regions of the OptiCell™ unit were sonicated separately by moving
the ultrasound device.
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ARTICLE IN PRESSwas added. After 48 h incubation, discs (22 mm in diameter)
were cut from the OptiCell™membrane, transferred to a 24-well
plate and lysed with 80 µl 1× CCLR buffer (Promega; Leiden,
The Netherlands) to measure both the luciferase activity and the
total protein concentration.
Luciferase activity was determined with the Promega luci-
ferase assay kit according to the manufacturer's instructions in
relative light units (RLU). Briefly, 100 µl substrate was added to
20 µl cell lysate and after a 2 s delay, the luminescence was
measured during 10 s with a GloMax™ 96 luminometer. To
correct for the amount of cells per well, the protein concentra-
tion was determined with the BCA kit (Pierce; Rockford, IL).
Therefore, 200 µl mastermix, containing 50 parts reagent A to 1
part B, was mixed with 20 µl cell lysate or BSA (to make thePlease cite this article as: R.E. Vandenbroucke, et al., Ultrasound assisted siRNA
doi:10.1016/j.jconrel.2007.12.001standard curve). After 30 min incubation at 37 °C, the absor-
bance at 590 nm was measured with a Wallac Victor2 absor-
bance plate reader (Perkin Elmer; Waltham, MA).
3. Results and discussion
3.1. Preparation and characterization of PEG-siPlex loaded
microbubbles
As schematically depicted in Fig. 1A, the first goal of thiswork
was to attach PEGylated siRNA–liposome complexes (PEG-
siPlexes) to gas-filled microbubbles via a biotin–avidin–biotin
bridge. Therefore, we first prepared perfluorobutane filled lipid
microbubbles by sonication of a DPPC/DSPE-PEG2000-biotin
liposome dispersion in the presence of perfluorobutane gas. The
lipid coating prevents a rapid diffusion of the perfluorobutane gas
out of the microbubbles. To assure that biotin molecules were
present at the outer surface of the microbubbles, we incubated
them with Cy5-labelled streptavidin. As shown by the confocal
images in Fig. 2A and B, after removal of the unbound strep-
tavidin, a thin fluorescent layer of streptavidin molecules sur-
rounding the gas-filled microbubbles could be observed, which
indicates the formation of biotin–avidin linkages. This suggestsdelivery using PEG-siPlex loaded microbubbles, J. Control. Release (2008),
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with their hydrophobic tails to the perfluorobutane gas core while
their hydrophilic head groups are exposed to the surrounding
aqueous medium, as previously suggested by Unger [38].
In a next step, we prepared DOTAP/DOPE based siPlexes
containing increasing amounts of DSPE-PEG2000-biotin (0, 2, 5
and 15 mol%). In all cases, a N:P ratio of 20:1 was chosen as
non-PEGylated siPlexes showed at this ratio the highest gene
silencing effect in HUH7 cells (data not shown). The ability of
the siPlexes to bind siRNAwas analyzed by PAGE (Fig. 3A). In
case of the 0, 2 and 5 mol% DSPE-PEG2000-biotin containing
siPlexes, no free siRNA could be detected. This implies that all
the siRNA is complexed with the liposomes, which are too large
to migrate into the gel network. In contrast, a smear of siRNA
was observed in case of the 15 mol% PEG-siPlexes, indicating
only a partial siRNA complexation in these siPlexes.
Subsequently, the ability of the different siPlexes to bind to
the surface of the biotinylated microbubbles was tested.
Therefore, the biotinylated microbubbles were first incubated
with avidin. An excess of avidin was used to avoid massive
clustering of the microbubbles, due to avidin mediated bridging.Fig. 3. (A) Polyacrylamide gel after electrophoresis of siPlexes containing 0 mol
% (lane 1), 2 mol% (lane 2), 5 mol% (lane 3) and 15 mol% DSPE-PEG2000-
biotin (lane 4) before attachment to the microbubbles. As a reference, free
siRNA was loaded in lane 5 and each lane contains 0.3 µg siRNA. (B–E)
Confocal laser scanning microscopy images and corresponding transmission
images (inserts) of avidinylated microbubbles incubated with siPlexes contain-
ing 0 mol% (B), 2 mol% (C), 5 mol% (D) and 15 mol% DSPE-PEG2000-biotin
(E). The siPlexes were visualized by using Atto488-siRNA.
Please cite this article as: R.E. Vandenbroucke, et al., Ultrasound assisted siRNA
doi:10.1016/j.jconrel.2007.12.001After removal of the unbound avidin, siPlexes, containing
Atto488 labelled siRNA, were added to the avidinylated micro-
bubbles. The confocal images in Fig. 3B till E show that the
amount of DSPE-PEG2000-biotin in the siPlexes clearly in-
fluences to which extent the microbubble surface becomes
covered with siPlexes. Non-PEGylated siPlexes (Fig. 3B), thus
not containing DSPE-PEG2000-biotin, only showed some non-
specific binding to the avidinylated microbubbles. In contrast, the
PEGylated siPlexes, containing DSPE-PEG2000-biotin, clearly
bound to the avidinylated surface of the microbubbles. The
surface of the microbubbles became only partially covered with
siPlexes containing 2 mol% DSPE-PEG2000-biotin (Fig. 3C),
probably due to the limited degree of biotinylation of the siPlexes.
In contrast, the microbubble surface was almost completely
coated with siPlexes when they contained 5 mol% DSPE-
PEG2000-biotin (Fig. 3D). The 15mol% containing PEG-siPlexes
also showed an efficient coating of the surface of the micro-
bubbles. However, as these siPlexes showed incomplete com-
plexation of the siRNA, previously shown by gel electrophoresis
experiments (Fig. 3A, lane 5), these siPlexes were further ex-
cluded from the study.
Subsequently we studied the size distribution of the siPlex
coated microbubbles by laser diffraction to assure that the
microbubbles had the optimal size distribution for cavitation.
Fig. 4 shows the size distribution of microbubbles incubated
with non-PEGylated siPlexes and microbubbles loaded with
PEGylated siPlexes. In both cases, the diameter of the micro-
bubbles varied between 0.5 and 10 µm, which is an appropriate
size to favour cavitation upon exposure to clinically relevant
ultrasound energy [38]. Fig. 4 (arrow) also shows a significant
amount of sub-micron particles in case of the non-PEGylated
siPlexes, indicating the presence of non-bound siPlexes. In
contrast, this sub-micron peak was not visible in case of the
microbubbles loaded with PEGylated siPlexes (Fig. 4, grey
circles). These results are in agreement with the confocal images
shown in Fig. 3B and D. Similar size distributions were found
for microbubbles that were loaded with 2 mol% DSPE-
PEG2000-biotin containing siPlexes (data not shown).
3.2. Ultrasound induced release of PEG-siPlexes from
microbubbles
It has been shown that coupling of polystyrene beads to the
surface of microbubbles via a biotin–avidin bridge, results in
local delivery of the beads upon ultrasound radiation [39].
However, in contrast to these inert beads, self-assembled
siPlexes may undergo physicochemical alterations during the
ultrasound triggered release, which may influence their bio-
logical performance. Therefore, we determined the size, zeta
potential and siRNA complexation of the siPlexes before
attachment to the microbubbles and after ultrasound triggered
release from the microbubbles.
The dark grey bars in Fig. 5A show that, before binding to the
microbubble surface the size of the siPlexes was independent of
the PEGylation degree and averaged 130 nm. In contrast, the
surface charge lowered with increasing degree of PEGylation
(dark grey bars in Fig. 5B) varying from 50 mV for the non-delivery using PEG-siPlex loaded microbubbles, J. Control. Release (2008),
Fig. 5. (A) Size and (B) zeta potential of the siPlexes containing 0 mol%, 2 mol%
and 5 mol% DSPE-PEG2000-biotin before attachment to the microbubbles (dark
grey bars) and after ultrasound assisted release from the siPlex loaded
microbubbles (light grey bars). The data are the means of three independent
measurements and the error bars represent standard deviations.
Fig. 4. Size distribution measured by laser diffraction of microbubbles after
addition of non-PEGylated siPlexes (black squares) and attachment of 5 mol%
DSPE-PEG2000-biotin containing siPlexes (grey circles). The data are the mean
of three measurements and error bars represent standard deviations. Arrow
indicates a peak of sub-micron sized particles.
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PEG2000-biotin. Fig. 5A also shows that binding and subsequent
ultrasound assisted release of the PEG-siPlexes from the
microbubbles (light grey bars) had only a limited effect on the
size of these PEG-siPlexes with a maximal increase of ∼20 nm,
in contrast to the clear increase in size of the non-PEGylated
siPlexes.
As observed for the size, the zeta potential (Fig. 5B) of the
PEG-siPlexes after being released from the microbubbles by
ultrasound was not significantly altered, while the zeta potential
of the non-PEGylated siPlexes was significantly lower. The
change in size and zeta potential of the non-PEGylated siPlexes
may be due the binding of negatively charged DSPE-PEG2000-
biotin lipids from the imploded microbubbles to the non-
PEGylated siPlexes.
Clearly, to keep their biological performance, the siPlexes
may not dissociate (i.e. release their siRNA) upon exposure to
ultrasound, as free siRNA is prone to nuclease degradation. Gel
electrophoresis revealed that ultrasound energy did not dis-
sociate the siPlexes (data not shown). In conclusion, ultrasound-
mediated implosion of the PEG-siPlex loaded microbubbles and
the induced microjets did not drastically influence the size, zeta
potential and the complexation properties of the released PEG-
siPlexes.
3.3. Cellular distribution of PEG-siPlexes
Next we studied the cellular distribution of PEG-siPlexes.
Fig. 6A till C shows HUH7 cells incubation with 5 mol% PEG-
siPlexes. The z-scan in Fig. 6A reveals that these PEG-siPlexes,
after 20 min incubation at 37 °C, were still located on top of the
HUH7 cells. This was confirmed by the images in Fig. 6B and
C. In these images, the green labelled PEG-siPlexes (Fig. 6C)
show exactly the same cellular distribution as the red labelled
plasma membrane (Fig. 6B). This confirms that PEGylation
indeed has an effect on the cellular uptake of siPlexes [40], as
non-PEGylated siPlexes were clearly taken up by the cells after
20 min (data not shown). Ultrasound irradiation did not changePlease cite this article as: R.E. Vandenbroucke, et al., Ultrasound assisted siRNA
doi:10.1016/j.jconrel.2007.12.001the cellular distribution of these free PEG-siPlexes (data not
shown). Interestingly, PEG-siPlexes released from siPlex
loaded microbubbles by ultrasound showed a totally different
cellular distribution (Fig. 6D till F). In this case, the green
labelled PEG-siPlexes were localized inside the cells as shown
by the z-scan (Fig. 6D) and the membrane colouring (Fig. 6E
and F). These results suggest that PEG-siPlexes enter the cells
via a different mechanism when they are released from the PEG-
siPLex loaded microbubbles by ultrasound. Although further
research is needed, we suppose that they enter cells via the
transient cell membrane perforations that arise during the
exposure to ultrasound [41]. Indeed, such pores, which have
been reported to be a few hundreds of nanometers in size
[34,42], are large enough to allow the passage of the PEG-
siPlexes released from the microbubbles. This implies that the
negative effects of PEGylation on the cellular uptake as well as
on the endosomal escape of PEG-siPlexes can be circumvented
by attaching them to microbubbles and subsequently expose
these siPlex loaded microbubbles to ultrasound.
3.4. Gene silencing efficiency of PEG-siPlex loaded micro-
bubbles
Finally, we determined whether siRNA delivered by ultra-
sound-mediated implosion of the PEG-siPLex loaded micro-
bubbles could inhibit constitutive luciferase expression indelivery using PEG-siPlex loaded microbubbles, J. Control. Release (2008),
Fig. 7. Silencing efficiency of free siPlexes and PEG-siPlexes in the absence and
presence of ultrasound, and PEG-siPlex loaded microbubbles in the presence of
ultrasound. The PEGylation (DSPE-PEG2000-biotin) degree of the siPlexes is
represented in the x-axis. The black and the dark grey bars represent the gene
silencing efficiency of free siPlexes in the absence and presence of ultrasound,
respectively. The light grey and white bars represent the gene silencing of the
siPlexes loaded on the microbubbles in the absence or presence of ultrasound. In
all cases, the following ultrasound settingswere used: 1MHz, 10%DC, 2W/cm2,
10 s. The results are expressed as percentage of luciferase expression compared to
mock siRNA transfected cells. The asterisks (⁎) represent significant differences
with pb0.05. (MB = microbubble; US = ultrasound).
Fig. 6. Cellular uptake and intracellular distribution of PEG-siPlexes (A till C)
and ultrasound irradiated PEG-siPlex loaded microbubbles (D till F). All PEG-
siPlexes contain 5 mol% DSPE-PEG2000-biotin. Images A and D display
confocal images and z-scans, at the positions indicated by the red lines, through
HUH7 cells with Draq5 labelled nuclei (blue) and incubated for 20 min with
Atto488-labelled siPlexes (green). Confocal images (B) and (E) show the
localisation of TRITC-concanavalin A (red), a plasma membrane marker.
Confocal images (C) and (F) show the localisation of Atto488-labelled siPlexes
(green) in the cells shown in images (B) and (E), respectively. The scale bars
represent 10 µm.
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ARTICLE IN PRESSHUH7eGFPLuc cells (Fig. 7). The black bars in Fig. 7 show that
the silencing capacity of the free siPlexes declines dramatically
with increasing PEGylation degree. siPlexes with a PEGylation
degree of 2 mol% already showed a 3-fold reduced gene silencing
capacity compared to the non-PEGylated siPlexes. Increasing the
PEGylation degree to 5 mol% even completely blocked the
silencing capacity of the siPlexes. This negative effect of
PEGylation has intensively been studied for pDNA delivery and
some groups suggest that the loss in transfection efficiency of
highly PEGylated lipoplexes is due to a reduced cellular binding
and uptake [43], while others believe that the PEG-lipids inhibit
the endosomal release of the nucleic acids into the cytoplasm [44–
48]. The white bars in Fig. 7 show that the negative effect of
PEGylation on the gene silencing efficiency of the siPlexes
containing 5 mol% DSPE-PEG2000-biotin can be completely
counteracted by loading of these PEG-siPlexes on the surface of
microbubbles followed by exposure of these microbubbles to
ultrasound. Attachment of siPlexes containing 2 mol% DSPE-
PEG2000-biotin to the microbubbles and subsequent exposure toPlease cite this article as: R.E. Vandenbroucke, et al., Ultrasound assisted siRNA
doi:10.1016/j.jconrel.2007.12.001ultrasound resulted in a similar silencing as the corresponding free
PEG-siPlexes. For these PEG-siPlexes the number of PEG-
siPlexes bound to the microbubbles is probably not enough to
further increase their gene silencing efficiency. Indeed, as shown
in Fig. 3C, the 5 mol%DSPE-PEG2000-biotin containing siPlexes
bind much more efficiently to the microbubble surface than the
2 mol% DSPE-PEG2000-biotin containing siPlexes (Fig. 3B).
Therefore, these datamay indicate that the extent of gene silencing
is governed by the amount of PEG-siPlexes that are released near
the cell perforations. Fig. 7 (dark grey bars) also shows that
applying ultrasound energy, in the absence ofmicrobubbles, could
not enhance the gene silencing efficiency of the different siPlexes.
Furthermore, microbubbles loaded with 5 mol% PEG-siPlexes
were not able to cause gene silencing in the absence of ultrasound
(Fig. 7; light grey bars). This implies that the PEG-siPlex loaded
microbubbles described in this work allow ultrasound controlled,
i.e. targeted, intracellular delivery of siRNA.
4. Conclusion
In conclusion, we developed a novel delivery system in
which PEG-siPlexes are attached to ultrasound responsive
microbubbles via a biotin–avidin–biotin bridge. Exposure of
these PEG-siPlex loaded microbubbles to ultrasound resulted in
a massive release of unaltered PEG-siPlexes. Furthermore,
PEG-siPlexes (containing 5 mol% DSPE-PEG2000-biotin)
loaded on microbubbles were able to enter cells rapidly after
exposure to ultrasound, while free PEG-siPlexes did not enter
cells. Moreover, these PEG-siPlex loaded microbubbles caused,delivery using PEG-siPlex loaded microbubbles, J. Control. Release (2008),
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ARTICLE IN PRESSin the presence of ultrasound, a much higher gene silencing than
free PEG-siPlexes. Interestingly, in the absence of ultrasound
these PEG-siPlex loaded microbubbles did not cause any gene
silencing. Therefore, the developed siRNA delivery system
allows both space and time controlled gene silencing. Further-
more, the PEG-siPlex loaded microbubbles are expected to be
suitable for systematic applications as ultrasound in combina-
tion with microbubbles is considered as a safe and already used
in the clinic for diagnostic purposes. Additionally, PEG-
siPlexes are known not to aggregate in serum which is im-
portant to avoid blockage of small blood capillaries by ag-
gregates [49]. The developed siRNA delivery system may also
allow the treatment of patients with metastasized tumours.
Indeed, a recently developed device that combines magnetic
resonance imaging (MRI) and ultrasound can both track down
the metastasized tumours and guide the ultrasound energy to
these tumours [50]. So, the siRNA delivery system presented in
this work may open up new perspectives for ultrasound
controlled in vivo delivery of siRNA.
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